NGM Biopharmaceuticals, Inc. NGM
1.54 +1.54
Day range unavailable
52-week range unavailable
Revenue & Expenses
Latest period ending Dec 31, 2023 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| 155.88M | 221.58M | 198.58M | 191.20M | 152.88M | |
| 118.04M | 181.07M | 161.71M | 163.97M | 129.25M | |
| 37.84M | 40.52M | 36.87M | 27.23M | 23.63M | |
| -155.88M | -221.58M | -198.58M | -191.20M | -152.88M | |
| -142.38M | -162.67M | -120.33M | -102.49M | -42.80M | |
| -142.38M | -162.67M | -120.33M | -102.49M | -42.80M | |
| -142.38M | -162.67M | -120.33M | -102.49M | -42.80M | |
| -142.38M | -162.67M | -120.33M | -102.49M | -42.80M | |
| -1.73 | -2.03 | -1.56 | -1.50 | -0.85 | |
| -1.73 | -2.03 | -1.56 | -1.50 | -0.85 | |
| -1.73 | -2.03 | -1.56 | -1.50 | -0.85 | |
| -142.38M | -162.67M | -120.33M | -102.49M | -42.80M | |
| -142.38M | -162.67M | -120.33M | -102.49M | -42.80M | |
| 82.50M | 79.95M | 77.08M | 68.47M | 50.30M | |
| 82.50M | 79.95M | 77.08M | 68.47M | 50.30M |